Alerts will be sent to your verified email
Verify EmailGENNEX
Positive for this company
Neutral for this company
Negative for this company
Insufficient data to analyse
Gennex Laboratories Ltd specializes in the production and export of bulk drugs and intermediates such as Guaiphenesin, Methocarbamol, Fluconazole, and Phenazopyridine.
Gennex Lab major competitors are Trident Lifeline, Lyka Labs, Vaidya Sane Ayur Lab, Zim Laboratories, Brooks Laboratories, Ambalal Sarabhai Ent, Medico Remedies.
Market Cap of Gennex Lab is ₹287 Crs.
While the median market cap of its peers are ₹237 Crs.
Gennex Lab seems to be less financially stable compared to its competitors.
Altman Z score of Gennex Lab is 4.68 and is ranked 4 out of its 8 competitors.
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Annual Report | FY26 | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | ||
| Earnings Release | Jun | ||||||||||||||||||
| Investor Presentation | |||||||||||||||||||
| Conference Call | |||||||||||||||||||
|
Conference Call SummaryCon Call Summary
Powered by Gemini
|